Dupilumab-Associated Mycosis Fungoides with a CD8+ Immunophenotype

Dupilumab is a humanized IgG4 monoclonal-antibody that is approved by the United States Food and Drug Administration (FDA) for the treatment of moderate-to-severe atopic dermatitis (AD) in patients aged 12 years and older. In recent years, several case studies have associated the unmasking or progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Ariel, Wong, Lulu, Lang, Annalise, Kraus, Christina, Anderson, Nancy, Elsensohn, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776571/
https://www.ncbi.nlm.nih.gov/pubmed/36547219
http://dx.doi.org/10.3390/dermatopathology9040045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776571/
https://www.ncbi.nlm.nih.gov/pubmed/36547219
http://dx.doi.org/10.3390/dermatopathology9040045

Ejemplares similares